Status:
COMPLETED
Artificial Intelligence for Detecting Retinal Diseases
Lead Sponsor:
Beijing Tongren Hospital
Collaborating Sponsors:
Beijing Tulip Partner Technology Co., Ltd, China
Conditions:
Artificial Intelligence
Retinal Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
The objective of this study is to apply an artificial intelligence algorithm to diagnose multi retinal diseases from fundus photography. The effectiveness and accuracy of this algorithm was evaluated ...
Detailed Description
The objective of this study is to apply an artificial intelligence algorithm to diagnose referral diabetes retinopathy, referral age-related macular degeneration, referral possible glaucoma, pathologi...
Eligibility Criteria
Inclusion
- fundus photography around 45° field which covers optic disc and macula
- complete identification information
Exclusion
- insufficient information for diagnosis.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
1000000 Patients enrolled
Trial Details
Trial ID
NCT04678375
Start Date
June 1 2018
End Date
October 1 2020
Last Update
April 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wen-Bin Wei
Beijing, Beijing Municipality, China, 100730